Stephen Rocamboli

Insider Reports History

Entity
Individual
Location
C/Oparmount Capital, 787 Seventh Ave 48 Th Fl, New York, NY
Signature
/s/ Stephen C. Rocamboli, by Kirk Allen Coleman, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stephen Rocamboli:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Esperion Therapeutics, Inc. Director Common Stock 36.3K $90K $2.48 May 23, 2024 Direct
Esperion Therapeutics, Inc. Director Stock Option (right to buy) 32.5K $52.7K $1.62 May 23, 2024 Direct
TFF Pharmaceuticals, Inc. Director Common Stock 39.2K $15.3K $0.39 Jul 3, 2024 Direct
TFF Pharmaceuticals, Inc. Director Restricted stock units 4.67K $1.83K $0.39 Apr 18, 2024 Direct
TFF Pharmaceuticals, Inc. Director Stock Options (Right to Buy) 3.17K Jul 3, 2024 Direct

Insider Reports Filed by Stephen Rocamboli

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TFFP TFF Pharmaceuticals, Inc. Jul 3, 2024 2 $0 4 Jul 8, 2024 Director
ESPR Esperion Therapeutics, Inc. May 23, 2024 2 $0 4 May 24, 2024 Director
TFFP TFF Pharmaceuticals, Inc. Apr 18, 2024 1 $0 4 Apr 22, 2024 Director
TFFP TFF Pharmaceuticals, Inc. Dec 1, 2023 1 $0 4 Dec 4, 2023 Director
TFFP TFF Pharmaceuticals, Inc. Aug 15, 2023 1 $5K 4 Aug 15, 2023 Director
ESPR Esperion Therapeutics, Inc. Jun 15, 2023 2 $0 4 Jun 16, 2023 Director
ESPR Esperion Therapeutics, Inc. May 10, 2023 1 $12.1K 4 May 11, 2023 Director
TFFP TFF Pharmaceuticals, Inc. Mar 10, 2023 1 $10.4K 4 Mar 13, 2023 Director
TFFP TFF Pharmaceuticals, Inc. Dec 29, 2022 1 $0 4 Dec 30, 2022 Director
ESPR Esperion Therapeutics, Inc. May 26, 2022 2 $0 4 May 27, 2022 Director
TFFP TFF Pharmaceuticals, Inc. May 16, 2022 1 $13.6K 4 May 17, 2022 Director
ESPR Esperion Therapeutics, Inc. Apr 28, 2022 0 $0 3 Apr 28, 2022 Director